BGI Genomics Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 3,152.09 million compared to CNY 3,638.86 million a year ago. Revenue was CNY 3,161.33 million compared to CNY 3,646.21 million a year ago.
Net income was CNY 605.9 million compared to CNY 1,086.02 million a year ago. Basic earnings per share from continuing operations was CNY 1.4806 compared to CNY 2.6593 a year ago. Diluted earnings per share from continuing operations was CNY 1.4803 compared to CNY 2.6458 a year ago.